Literature DB >> 27317365

Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems.

Mehdi Rezaee1, Reza Kazemi Oskuee2, Hooriyeh Nassirli3, Bizhan Malaekeh-Nikouei4.   

Abstract

Efficient gene therapy is mainly dependent on the gene transfer capability of gene delivery vectors. Non-viral vectors have become the research interest of many researchers because these vectors are safer than viral vectors. Acquiring the advantages of both polyplexes and lipoplexes, the lipopolyplex (LPP) is a ternary nanocomplex composed of cationic liposome, polycation, and nucleic acid. Considering the polycationic component, ternary complexes (LPPs) are divided into cationic polymer-based LPPs and cationic peptide-based LPPs. Considering the capability of rational design, LPP is an interesting field of research to design a more potent nucleic acid carrier. With the promising transfection activity and safety observed in the LPPs, many researchers have formulated various types of lipids and polycations to achieve an efficient and safe carrier for gene therapy. Here we provide a review on the designed LPPs for efficient delivery of different nucleic acids such as plasmid DNA, siRNA, shRNA, and DNA vaccines.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CHEMS, cholesteryl hemisuccinate (PubChem CID: 65082);; Chol, cholesterol (PubChem CID: 5997);; DDAB, dimethyldioctadecylammonium bromide (PubChem CID: 77293);; DMPE, dimyristoylphosphatidylethanolamine (PubChem CID: 114944);; DMPG, 1,2-ditetradecanoyl-sn-glycero-3-phospho-1′-rac-glycerol sodium salt (PubChem CID: 71311889);; DODAC, dioleyldimethylammonium chloride (PubChem CID: 6436349);; DOPC, 1,2-dioleoyl-sn-glycero-3-phosphocholine (PubChem CID: 10350317);; DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (PubChem CID: 44251425);; DOTAP, 1,2-dioleoyl-3-trimethylammonium-propane (PubChem CID: 107898);; DOTMA, N-[1-(2,3-dioleyloxy) propyl]-N,N,N-trimethlylammonium chloride (PubChem CID: 6438350);; DPPE, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (PubChem CID: 46907860);; DPTAP, 1,2-dipalmitoyl-3-trimethylammonium-propane (PubChem CID: 107898);; DTDTMA, ditetradecyl trimethyl ammonium (PubChem CID: 14251);; Gene delivery; Gene therapy; HZN, pyridylhydrazone (PubChem CID: 6436327);; IL-2 and 12, interleukin-2 and 12 (PubChem CID: 130138);; Lipopolyplexes; Non-viral vectors; PEG, poly(ethylene glycol) (PubChem CID: 174);; Rhod-DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) ammonium salt (PubChem CID: 44251425)

Mesh:

Substances:

Year:  2016        PMID: 27317365     DOI: 10.1016/j.jconrel.2016.06.023

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  36 in total

Review 1.  Biomaterial-Guided Gene Delivery for Musculoskeletal Tissue Repair.

Authors:  Justin L Madrigal; Roberta Stilhano; Eduardo A Silva
Journal:  Tissue Eng Part B Rev       Date:  2017-03-10       Impact factor: 6.389

2.  Transfection of primary brain capillary endothelial cells for protein synthesis and secretion of recombinant erythropoietin: a strategy to enable protein delivery to the brain.

Authors:  Annette Burkhart; Thomas Lars Andresen; Achim Aigner; Louiza Bohn Thomsen; Torben Moos
Journal:  Cell Mol Life Sci       Date:  2017-03-14       Impact factor: 9.261

3.  Selective attachment of a microtubule interacting peptide to plasmid DNA via a triplex forming oligonucleotide for transfection improvement.

Authors:  Caroline Girardin; Delphine Maze; Cristine Gonçalves; Yann Thierry Le Guen; Kevin Pluchon; Chantal Pichon; Tristan Montier; Patrick Midoux
Journal:  Gene Ther       Date:  2022-07-07       Impact factor: 5.250

4.  Determination of Optimum Ratio of Cationic Polymers and Small Interfering RNA with Agarose Gel Retardation Assay.

Authors:  Omer Aydin; Dilek Kanarya; Ummugulsum Yilmaz; Cansu Ümran Tunç
Journal:  Methods Mol Biol       Date:  2022

Review 5.  Recent advances in targeted delivery of non-coding RNA-based therapeutics for atherosclerosis.

Authors:  Xiaoxin Li; Hongzhao Qi; Weigang Cui; Zhibin Wang; Xiuxiu Fu; Tianxiang Li; Huibo Ma; Yanyan Yang; Tao Yu
Journal:  Mol Ther       Date:  2022-08-01       Impact factor: 12.910

6.  CD73 downregulation by EGFR-targeted liposomal CD73 siRNA potentiates antitumor effect of liposomal doxorubicin in 4T1 tumor-bearing mice.

Authors:  Anvar Soleimani; Farshad Mirzavi; Sara Nikoofal-Sahlabadi; Amin Reza Nikpoor; Bita Taghizadeh; Mehdi Barati; Mohammad Soukhtanloo; Mahmoud Reza Jaafari
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

7.  Attenuation of Maladaptive Responses in Aortic Adventitial Fibroblasts through Stimuli-Triggered siRNA Release from Lipid-Polymer Nanocomplexes.

Authors:  Chad T Greco; Robert E Akins; Thomas H Epps; Millicent O Sullivan
Journal:  Adv Biosyst       Date:  2017-07-20

8.  RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges.

Authors:  Ai-Ming Yu; Young Hee Choi; Mei-Juan Tu
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

Review 9.  RNA interference-based therapy and its delivery systems.

Authors:  Xiuhui Chen; Lingegowda S Mangala; Cristian Rodriguez-Aguayo; Xianchao Kong; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Cancer Metastasis Rev       Date:  2018-03       Impact factor: 9.264

10.  Multifunctional peptide-conjugated nanocarriers for pulp regeneration in a full-length human tooth root.

Authors:  Qian Li; Zhiai Hu; Yongxi Liang; Cancan Xu; Yi Hong; Xiaohua Liu
Journal:  Acta Biomater       Date:  2021-04-01       Impact factor: 10.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.